Jerusalem based Pepticom, a leader in artificial intelligence peptide drug discovery,  has secured $5 million in Series A funding from the Chartered Group. Pepticom’s unique

Jerusalem-based Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Swiss Lonza (SWX: LONN), an integrated healthcare solutions provider, have entered into a strategic

Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform Orgenesis Inc. a leading cell

The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation –  approved HIL’s Phase-II proposal, at a total budget of

Atox Bio, a late-stage clinical company developing immunotherapies for critically ill patients,  announced that the Biomedical Advanced Research and Development Authority (BARDA) has exercised the

KAHR Medical Ltd  , a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as DSP (Dual Signaling Proteins), announced 

Betalin Therapeutics‘ Micro Pancreas  will be tested on humans within 12 months. The biological pancreas contains living islet cells that are able to produce insulin but need

Israeli start-up Future Meat Technologies has secured $14 million in a seed funding round as it intends to build the world’s first cultured meat pilot

Carolina Partners, one of the most prominent mental and behavioral practices in the country, announced plans to offer patients access to BrainsWay‘s Deep Transcranial Magnetic